-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-fullreport.pdf
June 01, 2018 - Measuring IRR at the beginning of the abstraction process is imperative to identify and correct
any
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-fullreport.pdf
April 02, 2018 - Measuring IRR at the beginning of the abstraction process is imperative to identify and correct
any
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-fullreport.pdf
May 01, 2018 - Measuring IRR at the beginning of the abstraction process is imperative to identify and correct
any
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-fullreport.pdf
August 07, 2018 - Use of paper medical records versus administrative
data for measuring and improving health care quality
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-205-fullreport.pdf
January 01, 2014 - “It is critical to go beyond measuring screenings and have appropriate follow-up to ensure
services
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-fullreport.pdf
January 01, 2014 - 18 months, Parents’ Evaluation of Developmental
Status (PEDS), birth – 8 years) that are capable of measuring
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/meta/meta-analyses-refs.pdf
January 01, 2007 - Treating Tobacco Use and Dependence, 2008 Update: References for Studies in Meta-analyses
1
References for Studies Included in Meta-analyses
Table 6.4. Meta-analysis (1996): Impact of
having a tobacco use status identification
system in place on rates of clinician
intervention with their patients who smoke (n…